Pegylated liposomal doxorubicin HCL (PLD; Caelyx/Doxil®): Experience with long-term maintenance in responding patients with recurrent epithelial ovarian cancerEleni Andreopoulou, Franco M. Muggia, Allan J. Jacobs et al.|Annals of Oncology|2007Cited by 83
Ovarian Cancer in BRCA Mutation Carriers: Improved Outcome After Intraperitoneal (IP) CisplatinMaryann Kwa, Franco M. Muggia, Susan Edwards et al.|Annals of Surgical Oncology|2013Cited by 30
Lasting pathologic complete response to chemotherapy for ovarian cancer after receiving antimalarials for dermatomyositisIsabella Cadena, Franco M. Muggia, John P. Curtin et al.|ecancermedicalscience|2018Cited by 9